As discussed in the previous publications, inflammation also played a key role in the development of retinal ischemia-related ocular disorders (e.g., AMD), which includes the proven elevation of the inflammatory biomarkers, namely Cox-2 [17], MCP-1 [18], and iNOS [19]. This evidence concerns the gene CCL2 and retinal ischemia.